摘要 |
<p>The invention relates to compounds of formula I or pharmaceutically acceptable salts or solvates thereof: where Ar<SUB>1</SUB>, A Hy, R<SUB>1</SUB>, m and n are as defined in the description. The invention also includes pharmaceutical compositions and uses of, and processes of making the compounds, as well as methods of medical treatment of mGluR5-mediated disorders.</p> |
申请人 |
ASTRAZENECA AB;NPS PHARMACEUTICALS, INC.;EDWARDS, LOUISE;ISAAC, METHVIN;SLASSI, ABDELMALIK;SUN, GUANG-RI;XIN, TAO;MINIDIS, ALEXANDER;DOVE, PETER |
发明人 |
EDWARDS, LOUISE;ISAAC, METHVIN;SLASSI, ABDELMALIK;SUN, GUANG-RI;XIN, TAO;MINIDIS, ALEXANDER;DOVE, PETER |